Amplify CWP Enhanced Dividend Income ETF

Amplify ETF Trust · 1 share class

Actively managed U.S. equity ETF
One fund, 1 share class:DIVO
$7.19B NAV
32 positions · as of 2026-06-30 · filed 2026-08-28

Fund classification

Classified from what the fund holds · as of 2026 Q2

Amplify CWP Enhanced Dividend Income ETF is an actively managed U.S. equity ETF. 2% of DIVO’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 93% of the fund’s equity).

Asset class
Equity
Region
United States
Management
Actively managed
Fund type
ETF
Features
Non-diversified

Fund profile

As filed in the prospectus · 2026 Q1

The Amplify CWP Enhanced Dividend Income ETF seeks to provide a high level of risk -adjusted total return through a combination of current income and capital appreciation.

Strategy · summarised

The fund invests in approximately 20 to 25 large-cap dividend-paying stocks selected from the S&P 500, with active sector allocation and screening for companies with histories of increasing dividends and strong fundamentals. It opportunistically writes covered call options on these holdings to generate additional income from premiums. Because the fund is non-diversified and concentrates in a small number of issuers, performance depends heavily on the success of those individual picks. The covered call strategy caps gains beyond the strike price of sold options in exchange for premium income.

Expenses
0.56%one share class
Share classExpense ratio
DIVO0.56%

Portfolio turnover 94.00% · as of 2026 Q1

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q2

99.98%
of net assets
Stocks91.86%
Cash & short-term8.13%
Derivatives-0.01%

Look-through blends 1 underlying fund; 0.0% of NAV was not looked through and stays direct-classified.

The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.

Sector allocation

The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2

100%
of net assets
Financials21.3%
Information Technology15.9%
Industrials15.3%
Consumer Discretionary10.5%
9 smaller37.0%

Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).

Portfolio growth profile

How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2

Revenue growth
2%of stock holdings in top-quartile growers
covering 93% of the fund’s equity
Earnings growth
2%of stock holdings in top-quartile growers
covering 93% of the fund’s equity

Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.

Latest quarter

What changed since the fund's previous filing

2026Q2 vs 2026Q1: 6 new6 exited

Largest new: NVDA, FCX, ADM, FDXF

Largest exited: Medtronic PLC, META

Return profile

Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026

1-year
+22.32%
3-year
+49.33%
5-year
+68.85%
Volatility
6.97%
Worst 3-yr fall
-5.82%
Cumulative return· Jul 2023 – Apr 2026

May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
Caterpillar IncCAT6.98%$501.97M
Apple IncAAPL5.10%$366.88M
Microsoft CorpMSFT4.93%$354.37M
JPMorgan Chase & CoJPM4.86%$349.71M
The Goldman Sachs Group IncGS4.59%$330.51M
American Express CoAXP4.52%$324.95M
The TJX Cos IncTJX4.43%$318.80M
Amplify Samsung SOFR ETF4.31%$310.13M
Amgen IncAMGN4.19%$301.28M
CME Group IncCME3.98%$286.43M
Showing 10 of 32Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

Top 10 positions are 47.89% of net assets, top 25 92.75%, across 31 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free